BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
US |
|
InPlay Oil Corp
TSX:IPO
|
CA |
|
AirIQ Inc
F:EPXN
|
CA |
|
Consumer Portfolio Services Inc
NASDAQ:CPSS
|
US |
Wall St Price Targets
BCRX Price Targets Summary
BioCryst Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for BCRX is 21.726 USD with a low forecast of 13.13 USD and a high forecast of 33.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BCRX's stock price target?
Price Target
21.726
USD
According to Wall Street analysts, the average 1-year price target for BCRX is 21.726 USD with a low forecast of 13.13 USD and a high forecast of 33.6 USD.
What is the Revenue forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
-7%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -7%.
What is the Net Income forecast for BioCryst Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Net Income over the next 8 years is 20%.
